Eligibility
The 2025 EOI Period is now closed.
Entity Type
To be eligible for the Biointelect Venturer Program, applicants must:
- Be an Australian SME (registered Australian corporate entity with an ABN and fewer than 200 employees), or
- Be a researcher at an Australian university or medical research institute that will commit to incorporating a new company meeting the SME requirements prior to funding.
Important note: Biointelect Venturer funding will not cover company formation costs.
Intellectual Property
- Applicants must hold or secure transferable IP rights required to conduct and commercialise the technology.
Disease Area of Focus and Modality Requirements
- The project’s lead indication must directly address the prevention of a defined infectious disease in humans, rather than the management or treatment of another condition that directly or indirectly affects infection risk.
- Eligible technology types that have a direct preventative application include:
- Prophylactic vaccines;
- Prophylactic immunotherapies;
- Related technologies (e.g. delivery systems, adjuvants or platforms) that enable or enhance the prevention of infectious diseases;
- Other modalities that reduce infection risk or transmission — and are generally considered part of prevention strategies — such as diagnostics, biomarkers and prophylactic drugs, will also be considered based on their impact on the infectious disease prevention landscape.
Therapeutic interventions intended primarily to treat existing infections or diseases, host-directed therapies that reduce symptoms after infection onset, as well as Artificial Intelligence (AI) and digital health tools, software as a medical device, or devices designed solely to treat or manage established infections, are not eligible.
Stage of development
- Technologies must be at Technology Readiness Level (TRL) 3–6 at the time of application.
* Projects at TRL 2 will be considered in exceptional cases, if they are about to progress to TRL 3 or have credible plan plan to achieve TRL 4 within two years.
Other requirements
- Applicants must provide a letter of support from their Board/Executive leadership (for established companies) or Business Development Manager/Tech Transfer office (for researcher-led applicants at Australian-based Universities and Medical Research Institutes).
- Applicants must agree to reporting and monitoring requirements, including providing outcomes data and other metrics as requested during the program.
For further information on eligibility criteria, please refer to the Funding Guidelines.
For any queries about your application, email: venturer@biointelect.com.
